An FDA-approved drug for high blood pressure alleviates clinical symptoms of MS in mice, showing great promise for humans.
Focused ultrasound works like a noninvasive knife, cutting away amyloid plaques in mice. But is this new method safe and effective in humans?
Some patients who take aspirin have the potential for larger, more severe strokes. Highlights of the latest news about stroke are presented in this slide show.
Noninvasive measurements of cerebral hemodynamics and oxygenation can have a significant impact on the assessment of cerebrovascular conditions and can monitor the effects of clinical procedures on brain circulation.
Efficacy of acute medication matters beyond just treating a single migraine. It may increase the risk of worsened disease.
These agents lower cholesterol and prevent cardiovascular disease, but they may actually increase the risk of Parkinson disease. Caution advised.
Minimally invasive surgery to remove clots from the brain and other cutting-edge stroke news for neurologists highlighted the research and clinical program at the International Stroke Conference.
The ultimate cause is found in only about half of patients, so improved understanding of the prognostic and diagnostic features is of high priority.
This treatment may be superior to current treatment for patients with severe multiple sclerosis that is not responding well to standard treatments.
Drugs often involve multiple daily doses with complex dosing regimens, but interventions that have been applied generically to patients with chronic diseases can be applied to these cases as well.
The FDA has recently approved a number of drugs for a variety of neurologic disorders, including Parkinson's disease and MS. Here are 8 of the newest.
Favorable long-term results for patients with hard-to-treat epilepsy who undergo brain surgery offer good information for decision-making and counseling.
There is no approved screening tool for misophonia, but a case review can lead to a diagnosis. Several treatment options may aid in symptom management.
Scientists are testing alternative therapeutic approaches that may delay disease progression and even protect and regenerate neurons.
Anticholinergics could confer an increased risk, one dependent on the dose and amount of use. Give them to older patients or consider alternatives?